Abhijit Chakraborty
Overview
Explore the profile of Abhijit Chakraborty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
2060
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chakraborty A, Reisch T, Diem C, Astudillo-Estevez P, Thurner S
Nat Commun
. 2024 Apr;
15(1):3348.
PMID: 38637519
For centuries, national economies have been engaging in international trade and production. The resulting international supply networks not only increase wealth for countries, but also allow for economic shocks to...
12.
Lenz T, Zhang X, Chakraborty A, Ardakany A, Prudhomme J, Ay F, et al.
bioRxiv
. 2024 Feb;
PMID: 38405848
Over the last few decades, novel methods have been developed to study how chromosome positioning within the nucleus may play a role in gene regulation. Adaptation of these methods in...
13.
Dutta P, Saha D, Earle M, Prasad C, Singh M, Darswal M, et al.
Indian Heart J
. 2024 Feb;
76(1):1-5.
PMID: 38387552
Cardiovascular diseases (CVD) remain a major global health challenge, with an escalating impact on mortality despite advancements in managing conventional risk factors. This review investigates the intricate relationship between human...
14.
Ji Y, Schiller H, Yang S, Quinlan M, Darstein C, Huth F, et al.
Clin Pharmacokinet
. 2024 Jan;
63(2):155-170.
PMID: 38244190
Ribociclib is an orally bioavailable, selective cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor. CDK4/6 inhibition by ribociclib leads to retinoblastoma tumor suppressor protein (Rb) reactivation, thereby restoring Rb-mediated cell cycle...
15.
Tsimberidou A, Baysal M, Chakraborty A, Andersson B
Hum Vaccin Immunother
. 2023 Dec;
19(3):2290356.
PMID: 38114231
To overcome challenges associated with adoptive cell therapy (ACT), we developed a personalized autologous T-cell therapy program. Patients with advanced cancer with HLA-A *02:01 allele and tumor expression of PRAME,...
16.
Mishra A, Gupta A, Dagar G, Das D, Chakraborty A, Haque S, et al.
Vaccines (Basel)
. 2023 Nov;
11(11).
PMID: 38006053
Significant progress has been achieved in the realm of therapeutic interventions for multiple myeloma (MM), leading to transformative shifts in its clinical management. While conventional modalities such as surgery, radiotherapy,...
17.
Chakraborty A, Li Y, Zhang C, Li Y, Rebello K, Li S, et al.
Circulation
. 2023 Aug;
148(12):959-977.
PMID: 37555319
Background: Smooth muscle cell (SMC) phenotypic switching has been increasingly detected in aortic aneurysm and dissection (AAD) tissues. However, the diverse SMC phenotypes in AAD tissues and the mechanisms driving...
18.
Ji Y, Darstein C, Yang S, Quinlan M, Chakravartty A, Zarate J, et al.
J Clin Pharmacol
. 2023 Jul;
63(12):1359-1370.
PMID: 37464901
Ribociclib in combination with endocrine therapy (ET) is a globally approved treatment option for patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) and...
19.
Dozmorov M, Marshall M, Rashid N, Grible J, Valentine A, Olex A, et al.
Sci Rep
. 2023 May;
13(1):7522.
PMID: 37160896
No abstract available.
20.
Okonechnikov K, Camgoz A, Chapman O, Wani S, Park D, Hubner J, et al.
Nat Commun
. 2023 Apr;
14(1):2300.
PMID: 37085539
Ependymoma is a tumor of the brain or spinal cord. The two most common and aggressive molecular groups of ependymoma are the supratentorial ZFTA-fusion associated and the posterior fossa ependymoma...